Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.biofilgroup.net | |
Market Cap | 71.67 Cr. | |
Enterprise Value(EV) | 71.44 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.34 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 127.75 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.76 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 10.63 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 4.14 | Calculated using Price: 44.04 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.63 Cr. | 16,273,800 Shares |
FaceValue | 10 | |
About Biofil Chemicals & Pharmaceuticals Ltd. | ||
Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops |
1 Day |
|
-1.36% |
1 Week |
|
-3.20% |
1 Month |
|
-2.35% |
3 Month |
|
-2.42% |
6 Month |
|
-22.28% |
1 Year |
|
-21.65% |
2 Year |
|
-37.67% |
5 Year |
|
+224.16% |
10 Year |
|
+1996.15% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 13.53 | 13.47 | 13.28 | 18.09 | 3.64 | 3.60 | 8.46 | 8.01 | 4.24 | |
Return on Capital Employed (%) | 12.09 | 12.97 | 14.04 | 21.86 | 5.13 | 5.06 | 10.12 | 12.18 | 6.23 | |
Return on Assets (%) | 3.68 | 4.14 | 4.13 | 7.81 | 2.05 | 1.99 | 3.63 | 3.28 | 2.69 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 8 | 8 | 11 | 13 | 13 | 14 | 15 | 16 | 17 | 17 | |
Non Curr. Liab. | 0 | 0 | 0 | ||||||||
Curr. Liab. | 7 | 5 | 13 | 9 | 11 | 11 | 27 | 17 | 1 | 14 | |
Minority Int. | |||||||||||
Equity & Liab. | 15 | 14 | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | |
Non Curr. Assets | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 | |
Curr. Assets | 5 | 5 | 15 | 13 | 15 | 14 | 32 | 23 | 9 | 22 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 15 | 14 | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 7 | 6 | 13 | 13 | 12 | 23 | 30 | 36 | 22 | 30 | |
Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
Total Income | 7 | 6 | 14 | 14 | 12 | 23 | 30 | 37 | 23 | 30 | |
Total Expenditure | -6 | -5 | -12 | -11 | -11 | -22 | -28 | -34 | -21 | -29 | |
PBIDT | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | -1 | 0 | 0 | 0 | -1 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 1 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication In terms of Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed the public notice published in newspapers i.e. Free press Mumbai & Indore (in English) and Choutha Sansar (in Hindi) on 31st May 2023 regarding Audited Financial Results for the quarter and year ended 31st March 2023 in terms of Regulation 33 of SEBI ((Listing Obligations and Disclosure Requirements) Regulations 2015 to consider and approve the Audited Financial Results for the Quarter and year ended 31st March 2023 along with Auditors Report Statement of Assets and Liabilities and Cash Flow Statement. |
Tue, 30 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 30Th May 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the Company hereby submits Outcome of the Board Meeting held on Tuesday 30 May 2023 for the purpose of consideration and approval of Audited Financial Results of the Company for the quarter and year ended 31st March 2023 along with the Auditors Report thereon and consideration of other matters. |
Tue, 30 May 2023
Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March 2023 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are here enclosing the Audited Financial Results for the quarter as well as year ended 31st March 2023 duly approved by the Board of Directors at its meeting held today i.e. Tuesday 30th May 2023 together with Audit Report thereon Statement of assets and liabilities Cash Flow Statement & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
Tue, 06 Jun 2023 |
|
|
S Making Higher Highs for 2 Days |
|
|